News and Press

News and Press


Greiner Bio-One has acquired 3D Cell Culture Technology assets from Nano3D Biosciences, Inc. earlier this year. Please click here for more information.


Nano3D Biosciences has recently collaborated with Greiner Bio-One, the Scripps Research Institute, the Cold Spring Harbor Laboratory, and the Dana-Farber Cancer Institute on a paper that you can find here.



Nano3D Biosciences has recently been featured in this Nature article and this Nature Medicine article highlighting our 3D cell culture capabilities for toxicology, cancer research, and regenerative medicine.


Nano3D Biosciences announces our partnership with The Scripps Research Institute and Cold Springs Harbor Laboratory to advance high-throughput screening for cancer research, funded by the National Institute of Health and sponsored by Greiner Bio-One North America.


Check out the new paper from our collaborators at the University of Houston where they constructed a 3D culture using primary cardiomyocytes. They found that these constructs preserved both the phenotype and contractility of the cardiomyocytes in 3D. This model could be used as a simple means of testing cardiotoxicity in 3D cultures that replicate native tissue environment.

Read the paper here.


n3D and Biotek Instruments published an application note together in Biospektrum using their Cytation 5 to image migration of 3D cell cultures in the BiO Assay – Biospektrum (German)


Glauco Souza, President and CSO of Nano3D Biosciences, discusses Organovo and the future prospects and challenges in the bioprinting market – Motley Fool


n3D and SBH Sciences partner to offer services in lead compound optimization using magnetic 3D bioprinting – PR Newswire


n3D is pleased to announce an OEM agreement with Greiner Bio-One. Greiner Bio-One is a global leader in medical technology for clinical diagnostics, the pharmaceutical and diagnostic industries, and biotechnology. Greiner will sell and distribute n3D’s leading products in 3D cell culture and bioprinting under their label. We at n3D are excited to partner with Greiner Bio-One to help researchers develop organoids and assays with speed, reproducibility, and faithfulness to native tissue environments.